Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Sea level doesn’t rise at the same rate everywhere – we mapped where Antarctica’s ice melt would have the biggest impact - 25 Superstar Couples That Motivate Relationship Objectives
- 3Europe must reinvent warfare for ‘era of shocks,’ NATO’s Vandier says
- 4Bayer sues COVID vaccine makers over mRNA technology
- 5Israel's fractured opposition hands Netanyahu a full term
- 5 Great Youngster Care Administrations To Watch in 2024
- Vote In favor of Your Number one Sort Of Blossoms
- 6 Top of the line Lodgings All over The Planet, Which One Do You Concur With
- Marvel's X-Men are joining the battle in 'Avengers: Doomsday': Watch the teaser
- Quantum Computing’s Next Major Breakthroughs Could Come From Australia
- Extremely Rare Snub-Nosed Monkey Was Just Born for the First Time Outside of Asia
- NASA astronauts to return from space early due to an 'unexpected medical issue.' What happened — and when are they coming home?
- Step by step instructions to Look at Compact disc Rates: A Thorough Aide
- Pick Your #1 Japanese Food
